Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
As an Associate Director / Director of Patient Advocacy at Capricor, you will guide and advance Capricor’s U.S. patient advocacy strategy across the company’s portfolio. In this role, you will cultivate trusted, compliant relationships with patient advocacy organizations, elevate the patient voice across the enterprise, and ensure patient perspectives meaningfully inform strategy from development through commercialization. The ideal candidate brings deep experience partnering with advocacy communities, strong cross functional collaboration skills, and a commitment to patient centered impact in rare and specialty disease areas.